HAPAG LLOYD SAYS IT'S HARD TO DETERMINE IF US PLANS REGARDING THE BLOCKADE OF HORMUZ WILL BE IMPLEMENTED.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN EXPRESSES HOPE TO MAINTAIN PRACTICAL RELATIONS WITH NEW GOVERNMENT.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN STATES HUNGARIANS HAVE DECIDED AND THEIR DECISION IS RESPECTED.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN EXPRESSING DESIRE FOR POSITIVE RELATIONS WITH HUNGARY AND EUROPE.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN STATES THAT ACTIONS TO SUPPORT UKRAINE'S GOALS DO NOT AID IN PEACE.
(@FirstSquaw)
(@FirstSquaw)
IRANIAN TANKERS LEFT THE GULF THROUGH THE STRAIT OF HORMUZ ON MONDAY BEFORE A US-BLOCKADE WAS ANNOUNCED, WITH ONE OF THEM SAILING EMPTY.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN SAYS THERE ARE MANY UNCLEAR DETAILS ABOUT TRUMP'S EFFORT TO BLOCK IRANIAN PORTS.
(@FirstSquaw)
(@FirstSquaw)
KREMLIN SAYS THE RUSSIAN REQUEST FOR ENRICHED URANIUM FROM IRAN IS STILL VALID BUT NOT URGENTLY NEEDED AT THIS TIME.
(@FirstSquaw)
(@FirstSquaw)
FITCH WARNED THAT THE VIABILITY RATINGS OF SAUDI BANKS MAY BE AFFECTED BY AN EXTENDED CONFLICT WITH IRAN.
(@FirstSquaw)
(@FirstSquaw)
FITCH SAYS A LONGER IRAN CONFLICT COULD BOOST COMPETITION FOR LOCAL FUNDING AND ELEVATE FUNDING COSTS IN THE LONG RUN.
(@FirstSquaw)
(@FirstSquaw)
BANK OF ENGLAND IMPROVES PREPAREDNESS WITH NEW OPERATIONAL GUIDELINES.
(@FirstSquaw)
(@FirstSquaw)
Iran’s exiled Prince Reza Pahlavi told Sweden’s parliament on Monday that Iran’s future would ultimately be decided by its people, not by foreign forces.
“The battle in my country today is not between reformists and hardliners; It is between occupation and liberation; It is a
(@FirstSquaw)
“The battle in my country today is not between reformists and hardliners; It is between occupation and liberation; It is a
(@FirstSquaw)
ECB’S VUJCIC: ENERGY PRICE’S STILL VERY CLOSE TO ECB BASELINE SCENARIO
(@FirstSquaw)
(@FirstSquaw)
NIKE INC: HSBC CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $48 FROM $90
(@FirstSquaw)
(@FirstSquaw)
EU'S VON DER LEYEN: THERE CAN BE NO STABILITY IN THE MIDDLE EAST WHILE LEBANON IS IN FLAMES
(@FirstSquaw)
(@FirstSquaw)
LILLY'S JAYPIRCA (PIRTOBRUTINIB) GREATLY INCREASED PROGRESSION-FREE SURVIVAL WHEN COMBINED WITH A TIME-LIMITED VENETOCLAX TREATMENT IN PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED FOR CLL/SLL.
(@FirstSquaw)
(@FirstSquaw)
ELI LILLY'S CLL-322 TRIAL IS EXPECTED TO EXCEED THE RESULTS OF VENETOCLAX IN ITS FIRST PHASE 3 CLL TRIAL.
(@FirstSquaw)
(@FirstSquaw)